AzTrials
AzTrials

FrailtyFrail-NegrinNCT05893342

Frailty in the Perioperative Period

An observational study of Frailty, run by Hospital Universitario de Gran Canaria Doctor Negrín at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The presence of frailty is associated with a high risk of complications in the perioperative period, increasing morbidity and mortality, hospital stay, and loss of quality of life. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Frailty
What is being tested?
Preoperative frailty diagnostic
How many people
138 participants
Where
1 siteSpain
Study dates
1 Mar 2024to 30 Sep 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: All patients over 65 years old undergoing surgery will be visited 24 hours before the intervention to sign the informed consent and the preoperative evaluation will be carried out through the application of different scales that evaluate the frailty of the patient. The patient will be monitored from his admission to the hospital until discharge and up to 3 months after the day of surgery. Data will be collected on in-hospital complications (medical or surgical), days of hospital stay, unforeseen need for ICU admission, if there has been loss of instrumental or cognitive abilities, and in-hospital mortality data and up to 3 months after surgery.

Who may be able to join

  • Patients over 65 years old undergoing urgent or scheduled surgery

Who cannot join

  • Language barrier
  • Cognitive impairment or inability to assist in clinical assessment during the study
  • Refusal to participate in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ángel Becerra, PhD contact

+34676229025

angbecbol@gmail.com

Aurelio Rodriguez-Pérez, PhD contact

+34928450371

arodperp@gobiernodecanarias.org

Spain1 site, 1 recruiting
  • Ángel Becerra

    Las Palmas de Gran Canaria, Las Palmas, 35019

    Ángel Becerra, MD, +34676229025

    angbecbol@gmail.com

    Recruiting

Other trials in Spain

About this study

Official title: Perioperative Frailty and Postoperative Complications: a Prospective Study

The presence of frailty is associated with a high risk of complications in the perioperative period, increasing morbidity and mortality, hospital stay, and loss of quality of life. In this prospective observational study, an evaluation of frailty was performed in patients older than 65 years old who undergo scheduled and urgent surgery. 138 patients are being included. The main objective is to evaluate the prevalence of frailty in patients older than 65 years undergoing surgery in our hospital and its association with postoperative mortality.

Read the detailed description

The presence of frailty is associated with a high risk of complications in the perioperative period, increasing morbidity and mortality, hospital stay, and loss of quality of life. This is a prospective observational study in which an evaluation of frailty was performed in patients older than 65 years old who undergo scheduled and urgent surgery, including 138 patients. The main objective is to evaluate the prevalence of frailty in patients older than 65 years undergoing surgery and its association with postoperative mortality. The secondary objectives were the following: to assess the association between frailty and increased days of hospital stay, hospital readmission, and unexpected admission to ICU areas; to assess whether patients with greater frailty suffer a greater loss of postoperative functional independence; to evaluate type and frequency of complications; and to evaluate which scale is most useful to implement in the perioperative setting (Frailty Clinical Scale, Edmonton frailty test, Barthel Index, Mini-mental test, Charlson Index). Considering that the estimated percentage of frailty is 10%, with a 95% confidence interval and a 5% error margin, 138 patients are needed to accurately estimate the prevalence of frailty in the population.

Conditions
Frailty
Being tested
Preoperative frailty diagnostic
Keywords
Preoperative frailty, Postoperative complications
Medical subject headings
Frailty, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Preoperative frailty diagnosticDiagnostic test

    The preoperative evaluation of the patient will be carried out through the application of different scales that evaluate frailty (Edmonton frailty test, Barthel Index, Mini-mental test, Charlson Index) and a postoperative follow-up will be carried out for the diagnosis of complications during the first 90 postoperative days.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of frailty

    Prevalence of frailty in patients older than 65 years undergoing surgery in our hospital

    Measured: First preoperative day

  2. Postoperative complications

    Relationship of preoperative frailty in patients older than 65 years undergoing surgery in our hospital and postoperative mortality

    Measured: 90 postoperative days

Secondary outcomes (2)
  1. Postoperative evolution

    To evaluate the association between frailty and increased days of hospitalization, hospital readmission and unexpected admission to ICU areas.

    Measured: 90 postoperative days

  2. Functional independence

    To assess whether patients with greater frailty suffer a greater loss of postoperative functional independence.

    Measured: First postoperative year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2023
  2. Study start1 Mar 2024
  3. Primary completion30 Sep 2025 (estimated)
  4. Study completion30 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
138 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05893342
Sponsor's protocol ID
2019-343-1
Acronym
Frail-Negrin
Status last verified
Aug 2025
First submitted
29 May 2023
Last updated
24 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual participant data could be available after request to the principal investigator

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty, run by Hospital Universitario de Gran Canaria Doctor Negrín at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ángel Becerra, PhD (+34676229025, angbecbol@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of frailty (time frame: First preoperative day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in